Fortress Biotech Inc. (FBIO)
FBIO trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.95
-7.58% on the day
Market cap
$65.0M
Micro cap
Revenue · 2025
$63.3M
+9.7% on 2024
Net income · 2025
$37.0M
58.5% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | FBIO on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001429260 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $63.3M |
| Net income | $37.0M |
| Operating income | -$70.2M |
| Net margin | 58.5% |
| Operating margin | -111.0% |
| Revenue growth | +9.7% |
| Cash | $79.4M |
| Total assets | $185.5M |
| P/E (computed) | 1.8× |
| P/S (computed) | 1.0× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2025-12-18 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-10-01 |
| Latest proxy | DEFA14A | 2026-04-28 |
Source: SEC EDGAR submissions feed, 885 recent filings. All filings on EDGAR.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| FBIOP | Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock | $17.41 |
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| RNTX | Rein Therapeutics Inc. | $0.7546 | -3.86% | $65.1M |
| SDEV | Stablecoin Development Corporation | $1.25 | -11.35% | $64.7M |
| ONCY | Oncolytics Biotech Inc. | $0.4900 | +3.53% | $64.2M |
| XBIT | XBiotech Inc. | $2.16 | -5.68% | $65.9M |
| SPRO | Spero Therapeutics Inc. | $1.15 | -2.54% | $67.0M |
| OSTX | OS Therapies Incorporated | $1.45 | -7.05% | $67.4M |
| APLM | Apollomics Inc. | $21.32 | 0.00% | $61.7M |
| CING | Cingulate Inc. | $4.72 | -2.48% | $68.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier